Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 2/20 | 0.60 |
| ▸ | ACACB | O00763 | 5/20 | 0.47 |
| ▸ | NAMPT | P43490 | 7/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.45 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | SCD5 | Q86SK9 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2801194 | 0.86 | GPR119 (0.53) | NAMPTGPR119TSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL485507 | 0.84 | ITGB3 (0.47) | HIF1ACYP2C9CYP2D6TSHRALDH1A1 | |
| SCHEMBL484102 | 0.84 | HIF1A (0.63) | CYP11B2HIF1ACYP2C9CYP2D6TSHR | |
| SCHEMBL484816 | 0.82 | GPR119 (0.65) | CYP11B2ACACBNAMPTHIF1AGPR119 | |
| SCHEMBL2419062 | 0.82 | GPR119 (0.53) | NAMPTGPR119TSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL1779308 | 0.79 | MAPK1 (0.55) | CYP11B2NAMPTHIF1AGPR119CYP2C9 | |
| SCHEMBL13156810 | 0.79 | CYP11B2 (0.61) | CYP11B2ACACBNAMPTHIF1AGPR119 | |
| SCHEMBL30984892 | 0.79 | ACACB (0.55) | CYP11B2ACACBNAMPTSCD5CYP3A4 | |
| SCHEMBL30985209 | 0.79 | CYP11B2 (0.56) | CYP11B2ACACBNAMPTSCD5CYP11B1 | |
| SCHEMBL30042024 | 0.78 | CYP3A4 (0.67) | CYP11B2HIF1ACYP2C9CYP2D6TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130231327-A1 | Substituted Spiro-Amide Compounds | GRUENENTHAL GMBH (DE) | 2013-09-05 | — | — | US | disclosed |
| US-8455475-B2 | Substituted spiro-amide compounds | GRUENENTHAL GMBH (DE) | 2013-06-04 | — | — | US | disclosed |
| EP-2411381-A1 | SUBSTITUTED SPIRO-AMIDE COMPOUNDS | Grünenthal GmbH (DE) | 2012-02-01 | — | — | EP | disclosed |
| US-20100249095-A1 | Substituted Spiro-amide Compounds | GRUENENTHAL GMBH (DE) | 2010-09-30 | — | — | US | disclosed |
| WO-2010108651-A1 | SUBSTITUTED SPIRO-AMIDE COMPOUNDS | Grünenthal GmbH (DE) | 2010-09-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130231327-A1 | Substituted Spiro-Amide Compounds | BDKRB1, BDKRB2, REN | CYP11B2 2150/4885ACACB 4258/4885NAMPT 2232/4885 |
| US-20100249095-A1 | Substituted Spiro-amide Compounds | BDKRB1, BDKRB2, REN | CYP11B2 2150/4885ACACB 4258/4885NAMPT 2232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.